The Molecular Imaging Market is projected to reach USD 12.5 billion by 2032 with a 4.5% CAGR.

From GlobeNewswire: 2025-04-10 09:20:00

The Molecular Imaging Market was valued at USD 8.47 billion in 2023 and is projected to reach USD 12.5 billion by 2032, with a CAGR of 4.5% during 2024-2032. Factors driving growth include the demand for precision medicine, rising cancer and neurological disorders incidence, and advances in imaging technology.

Molecular imaging plays a crucial role in modern medicine, providing non-invasive visualization of biological processes. In 2023, the U.S. dominated the North American market with 76% share, driven by advanced imaging tech adoption and significant government funding for medical research, including a USD 2.5 billion investment by the NIH in cancer research.

Key companies in the Molecular Imaging Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, and Medtronic. These companies offer various imaging technologies like PET/CT scanners, MRIs, and laser systems, contributing to market growth.

In 2023, the SPECT segment held a 42% revenue share in the market due to its applications in cardiology, oncology, and neurology. The segment’s growth is fueled by advancements like hybrid SPECT/CT systems, availability of radiopharmaceuticals, and increasing cardiovascular disease incidence, with a focus on developing portable systems and integrating AI for image analysis.

The oncology application segment led the market in 2023 with a 32% share, driven by the rising global cancer prevalence. Molecular imaging modalities like PET-CT and SPECT play a crucial role in early tumor staging and treatment monitoring, with the development of targeted radiotracers enhancing imaging efficacy.

Hospitals accounted for the highest share of 48% in 2023, driven by high patient inflow, advanced imaging facilities, and AI-powered systems. Partnerships between hospitals and diagnostic centers, along with government investments in healthcare infrastructure, are boosting hospital-based molecular imaging, with hybrid imaging systems facilitating diagnosis in tertiary care settings.

North America held the largest market share of 43% in 2023, with the U.S. dominating due to FDA approvals for imaging agents and systems. Europe closely followed, led by Germany and the UK, supported by Horizon Europe funding. The Asia-Pacific region is expected to be the fastest-growing market, driven by healthcare infrastructure development and investments in diagnostic tech in countries like India, Japan, and China. Japan’s high cancer incidence and aging population are driving demand for advanced imaging technology. In 2023, the FDA approved Siemens Healthineers’ new PET-CT scanner for early cancer detection. GE Healthcare also launched a next-generation SPECT/CT system to improve diagnostic efficiency in cardiology and oncology.

The Molecular Imaging Market Analysis & Outlook Report 2024-2032 covers key points such as market dynamics, statistical insights, adoption rates, and healthcare expenditure. It includes sections on market modality, application, end-use, regional analysis, and company profiles. SNS Insider offers comprehensive research and consulting services to provide clients with current, accurate market data for informed decision-making.



Read more at GlobeNewswire: Molecular Imaging Market to Hit USD 12.5 Billion by 2032,